Synedica Tirzepatide 40mg + GLOW Skin 112mg Bundle

The Synedica Tirzepatide 40mg + GLOW Skin 112mg Bundle brings together two Synedica formulations designed for research into different peptide and biological pathways.

Bundle Includes

1 × Synedica Tirzepatide 40mg Pen

Tirzepatide is described on the product packaging as a dual agonist of GLP-1 and GIP receptors.

The product packaging displays a total labelled content of 40mg, supplied as 4 × 10mg doses. The box contains one pen, 12 disposable needles, and one instruction booklet.

1 × Synedica GLOW Skin 112mg Pen

The GLOW Skin formulation contains:

• GHK-Cu — 80mg
• BPC-157 — 16mg
• TB-500 — 16mg

The packaging describes the formulation in connection with skin rejuvenation, anti-aging, and recovery research.

The product contains a total labelled content of 112mg and is supplied as a pen format formulation.

Combined Bundle Content ( Synedica Tirzepatide 40mg + GLOW Skin 112mg Bundle  )

• Synedica Tirzepatide — 40mg
• Synedica GLOW Skin — 112mg
• 152mg combined labelled content

Both products are supplied in pen format, with product packaging indicating disposable needles and instruction materials.

Key Features

• Synedica research bundle
• 1 × Tirzepatide 40mg Pen
• 1 × GLOW Skin 112mg Pen
• 152mg combined labelled content
• GLOW Skin contains GHK-Cu, BPC-157 & TB-500
• Tirzepatide research formulation
• Convenient two-product research bundle
• Pen-format formulations
• 12 disposable needles included with each product according to packaging
• Instruction booklet included with each product

How to Use (Research Reference Only)

These products are intended exclusively for laboratory and scientific research conducted by qualified professionals using appropriate research protocols.

Experimental handling, preparation, storage, and application should follow relevant laboratory procedures and institutional requirements.

Not intended for human consumption or self-administration.

Research Applications

The individual formulations may be investigated in research involving:

• GLP-1 and GIP receptor pathways
• Metabolic signalling
• Peptide-receptor interactions
• Cellular signalling
• Skin and tissue biology
• Recovery-related research
• Molecular and biochemical pathways
• Multi-component peptide research

Research Disclaimer

For laboratory and scientific research use only. ( Synedica Tirzepatide 40mg + GLOW Skin 112mg Bundle ).

Not intended for human consumption, therapeutic use, diagnosis, treatment, or prevention of disease.

What is Included in the Synedica Tirzepatide 40mg + GLOW Skin 112mg Bundle ?

The bundle combines a 40mg Synedica Tirzepatide Pen with a 112mg Synedica GLOW Skin Pen. The GLOW Skin formulation contains 80mg GHK-Cu, 16mg BPC-157 and 16mg TB-500, providing 152mg of combined labelled content across the two products.